The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
dc.contributor.author | Coleman, R E | |
dc.contributor.author | Winter, M C | |
dc.contributor.author | Cameron, D | |
dc.contributor.author | Bell, R | |
dc.contributor.author | Dodwell, D | |
dc.contributor.author | Keane, M M | |
dc.contributor.author | Gil, M | |
dc.contributor.author | Ritchie, D | |
dc.contributor.author | Passos-Coelho, J L | |
dc.contributor.author | Wheatley, D | |
dc.contributor.author | Burkinshaw, R | |
dc.contributor.author | Marshall, S J | |
dc.contributor.author | Thorpe, H | |
dc.date.accessioned | 2018-09-20T16:03:42Z | |
dc.date.available | 2018-09-20T16:03:42Z | |
dc.date.issued | 2010-03-16 | |
dc.identifier.citation | Coleman, R E; Winter, M C; Cameron, D; Bell, R; Dodwell, D; Keane, M M; Gil, M; Ritchie, D; Passos-Coelho, J L; Wheatley, D; Burkinshaw, R; Marshall, S J; Thorpe, H (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer 102 (7), 1099-1105 | |
dc.identifier.issn | 0007-0920,1532-1827 | |
dc.identifier.uri | http://hdl.handle.net/10379/10844 | |
dc.publisher | Springer Nature | |
dc.relation.ispartof | British Journal of Cancer | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | |
dc.subject | anti-tumour activity | |
dc.subject | breast cancer | |
dc.subject | chemotherapy | |
dc.subject | neoadjuvant | |
dc.subject | pathological response | |
dc.subject | zol | |
dc.subject | surgical adjuvant breast | |
dc.subject | preoperative chemotherapy | |
dc.subject | pathological assessment | |
dc.subject | systemic therapy | |
dc.subject | doxorubicin | |
dc.subject | bisphosphonates | |
dc.subject | disease | |
dc.subject | carcinoma | |
dc.subject | survival | |
dc.subject | issues | |
dc.title | The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer | |
dc.type | Article | |
dc.identifier.doi | 10.1038/sj.bjc.6605604 | |
dc.local.publishedsource | http://www.nature.com/bjc/journal/v102/n7/pdf/6605604a.pdf | |
nui.item.downloads | 0 |